- Home
- HSTM vs QURE Comparison
HSTM vs QURE Comparison
Compare HSTM & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSTM
- QURE
- Stock Information
- Founded
- HSTM 1990
- QURE 1998
- Country
- HSTM United States
- QURE Netherlands
- Employees
- HSTM N/A
- QURE N/A
- Industry
- HSTM Computer Software: Programming Data Processing
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- HSTM Technology
- QURE Health Care
- Exchange
- HSTM Nasdaq
- QURE Nasdaq
- Market Cap
- HSTM 828.5M
- QURE 866.3M
- IPO Year
- HSTM 2000
- QURE 2007
- Fundamental
- Price
- HSTM $29.00
- QURE $14.84
- Analyst Decision
- HSTM Hold
- QURE Strong Buy
- Analyst Count
- HSTM 2
- QURE 11
- Target Price
- HSTM $28.00
- QURE $39.91
- AVG Volume (30 Days)
- HSTM 197.2K
- QURE 985.6K
- Earning Date
- HSTM 10-20-2025
- QURE 11-04-2025
- Dividend Yield
- HSTM 0.43%
- QURE N/A
- EPS Growth
- HSTM 14.03
- QURE N/A
- EPS
- HSTM 0.67
- QURE N/A
- Revenue
- HSTM $295,211,000.00
- QURE $14,337,000.00
- Revenue This Year
- HSTM $4.90
- QURE N/A
- Revenue Next Year
- HSTM $5.12
- QURE $301.10
- P/E Ratio
- HSTM $43.14
- QURE N/A
- Revenue Growth
- HSTM 3.50
- QURE N/A
- 52 Week Low
- HSTM $25.36
- QURE $4.45
- 52 Week High
- HSTM $34.24
- QURE $19.18
- Technical
- Relative Strength Index (RSI)
- HSTM 65.48
- QURE 38.59
- Support Level
- HSTM $27.33
- QURE $17.03
- Resistance Level
- HSTM $29.44
- QURE $17.76
- Average True Range (ATR)
- HSTM 0.50
- QURE 0.88
- MACD
- HSTM 0.09
- QURE -0.19
- Stochastic Oscillator
- HSTM 79.15
- QURE 3.74
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.